Imagine accelerating the discovery of new therapeutics through the development of AI models for mining drug-cell interactions at unprecedented resolution. Tahoe Therapeutics (formerly Vevo) new release may have redefined the race to map the human cellular landscape in cancer.
AI and data driven drug-discovery.
In an unusual move, Tahoe Therapeutics has released “Tahoe 100M”, a massive open-source dataset encompassing 100 million single-cell data points and 60,000 experiments,…
Continue Reading
News Source: www.forbes.com

Leave a Reply